The genetically engineered mouse model will be utilised to test whether blockade of STAT3 in earlier stages of NF1-associated nerve sheath tumour progression in plexiform neurofibroma and/or MPNST may have utility in MPNST chemoprevention. This evidence concerns the gene STAT3 and malignant peripheral nerve sheath tumor.